UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





Amendment No. 1

to

FORM 40-F/A





| ̈ | REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934   
|- | ---------------------------------------------------------------------------------------
|  |                                                                                        
|x | ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



For the fiscal year ended June 30, 2023 Commission
File Number 001-41175





SANGOMA TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)










Ontario, Canada 7370 Not applicable

|(Province or other jurisdiction of incorporation or organization) |  | (Primary standard industrial classification code number, if applicable) |  | (I.R.S. Employer Identification No., if applicable)
|----------------------------------------------------------------- |  | ----------------------------------------------------------------------- |  | ---------------------------------------------------



100 Renfrew Drive

Suite 100

Markham, Ontario, Canada L3R 9R6

(905) 474-1990

(Address and telephone number of registrant’s
principal executive offices)



CT Corporation System

28 Liberty Street

New York, New York 10005

(212) 894-8940

(Name, address (including zip code) and telephone
number (including area code) of agent for service in the United States)










Securities registered pursuant to Section 12(b) of
the Act:



Title of each class: Trading Symbol(s): Name
of each exchange on which register Common Shares, no par value SANG Nasdaq Global Select Market



Common Shares, no par value STC Toronto Stock Exchange



Securities registered pursuant to Section 12(g) of
the Act: None



Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act: None For annual reports, indicate by check mark the information filed with this form:



|x | Annual Information Form | x | Audited Annual Financial Statements
|- | ----------------------- | - | -----------------------------------










Indicate the number of outstanding shares of the
issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 33,038,367 Common Shares
(as at June 30, 2023).



Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months
(or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements
for the past 90 days.



Yes x
No  ̈



Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (s.232.405
of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).



Yes x
No  ̈



Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company



Yes x No
 ̈



If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the
Exchange Act.



Yes  ̈ No
x



† The term “new or revised financial
accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification
after April 5, 2012.



Indicate by check mark whether the registrant
has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report.



Yes  ̈ No
x



If securities are registered pursuant to Section 12(b) of
the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an
error to previously issued financial statements.  ̈



Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s
executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ̈




















EXPLANATORY NOTE



Sangoma Technologies Corporation (the “Registrant”)
is filing this Amendment No. 1 (this “Amendment No. 1”) to its original Annual Report on Form 40-F for the year ended June
30, 2023, which was filed with the Securities and Exchange Commission on September 27, 2023 (the “Original 2023 Annual Report”),
in order to refile Exhibit 99.2 to the Original 2023 Annual Report.



This Amendment No. 1 consists of a cover page, this explanatory note,
the signature page, the exhibit index, Exhibit 99.2, Exhibit 99.4 and Exhibit 99.5. Other than expressly set forth herein, this Amendment
No. 1 does not, and does not purport to, amend or restate any other information contained in the Original 2023 Annual Report nor does
this Amendment No. 1 reflect any events that have occurred after the Original 2023 Annual Report was filed.













SIGNATURES



Pursuant to the requirements of the Exchange Act,
the Registrant certifies that it meets all of the requirements for filing on Form 40- F and has duly caused this Amendment No. 1
to this Annual Report to be signed on its behalf by the undersigned, thereto duly authorized.



Date: September 28, 2023



| | Sangoma Technologies Corporation
| | --------------------------------
| |                                 
| | By:                             
| | Name:                           
| | Title:                          













|Exhibit Index
|-------------
|             
|Exhibit No.  
|99.1         
|99.2         
|99.3         
|99.4         
|99.5         
|99.6         
|99.7         
|(101.INS)    
|             
|(101.SCH)    
|(101.CAL)    
|(101.DEF)    
|(101.LAB)    
|(101.PRE)    
|(104)        



(*) Filed as an exhibit to the Original 2023 Annual Report.



(**) Filed as an exhibit to this Amendment No. 1 to the Original
2023 Annual Report.